TORONTO, Dec. 10, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”),…
December 10, 2025 18:00 ET | Source: Fortrea Holdings Inc DURHAM, N.C., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq:…
NEW YORK, Dec. 10, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…
Platform now provides unique insights into market dynamics and competitive strategiesSOMERSET, N.J., Dec. 10, 2025 /PRNewswire/ -- VCTI, a technology and…
December 09, 2025 21:42 ET | Source: Dyne Therapeutics, Inc. WALTHAM, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc.…
December 09, 2025 17:15 ET | Source: CPI Aerostructures, Inc. EDGEWOOD, N.Y., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CPI Aerostructures,…
YANTAI, China, Dec. 9, 2025 /PRNewswire/ -- On December 7, Linglong Tire convened its 50th Anniversary Global Partners Conference in Zhaoyuan,…
December 08, 2025 21:04 ET | Source: InnoCare Pharma BEIJING, Dec. 08, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969;…
SecureTech Backing Enables AI UltraProd’s U.S. Accessory Dwelling Unit Beachhead; 2026 Rollout and Expansion Strategy Roseville, Minnesota, Dec. 08, 2025…
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF)…